Terms: = Skin cancer AND SEPT9, PNUTL4, 10801, ENSG00000184640, MSF1, KIAA0991, AF17q25, MSF, SeptD1, SINT1
21 results:
1. A chest CT-based nomogram for predicting survival in acute myeloid leukemia.
Yi X; Zhan H; Lyu J; Du J; Dai M; Zhao M; Zhang Y; Zhou C; Xu X; Fan Y; Li L; Dong B; Jiang X; Xiao Z; Zhou J; Zhao M; Zhang J; Fu Y; Chen T; Xu Y; Tian J; Liu Q; Zeng H
BMC Cancer; 2024 Apr; 24(1):458. PubMed ID: 38609917
[TBL] [Abstract] [Full Text] [Related]
2. Restrospective reappraisal of the prognostic classification of spitzoid melanocytic neoplasms after BRAF and NRAS mutation characterisation: a single institution experience.
Moysset I; Castrejon N; Garcia-Herrera A; Castillo P; Marginet M; Teixido C; Podlipnik S; Albero-Gonzalez R; Montironi C; Navarro J; Rovira C; Puig S; Carrera C; Alos L
Histopathology; 2024 Jun; 84(7):1154-1166. PubMed ID: 38409889
[TBL] [Abstract] [Full Text] [Related]
3. Convolutional Neural Network with Multiscale Fusion and Attention Mechanism for skin Diseases Assisted Diagnosis.
Li Z; Wang H; Han Q; Liu J; Hou M; Chen G; Tian Y; Weng T
Comput Intell Neurosci; 2022; 2022():8390997. PubMed ID: 35747726
[TBL] [Abstract] [Full Text] [Related]
4. Role of Qualitative and Quantitative Indocyanine Green Angiography to Assess Mastectomy skin Flaps Perfusion in Nipple/skin-Sparing and skin-Reducing Mastectomies with Implant-Based Breast Reconstruction.
Mastronardi M; Fracon S; Scomersi S; Fezzi M; Bortul M
Breast J; 2022; 2022():5142100. PubMed ID: 35711883
[TBL] [Abstract] [Full Text] [Related]
5. Migration Stimulating Factor (msf): Its Role in the Tumour Microenvironment.
Schor AM; Woolston AM; Kankova K; Harada K; Aljorani LE; Perrier S; Felts PA; Keatch RP; Schor SL
Adv Exp Med Biol; 2021; 1329():351-397. PubMed ID: 34664248
[TBL] [Abstract] [Full Text] [Related]
6. Biomarker-guided heterogeneity analysis of genetic regulations via multivariate sparse fusion.
Zhang S; Hu X; Luo Z; Jiang Y; Sun Y; Ma S
Stat Med; 2021 Jul; 40(17):3915-3936. PubMed ID: 33906263
[TBL] [Abstract] [Full Text] [Related]
7. CDC42EP5/BORG3 modulates sept9 to promote actomyosin function, migration, and invasion.
Farrugia AJ; Rodríguez J; Orgaz JL; Lucas M; Sanz-Moreno V; Calvo F
J Cell Biol; 2020 Sep; 219(9):. PubMed ID: 32798219
[TBL] [Abstract] [Full Text] [Related]
8. Integrating Next-Generation Sequencing with Morphology Improves Prognostic and Biologic Classification of Spitz Neoplasms.
Quan VL; Zhang B; Zhang Y; Mohan LS; Shi K; Wagner A; Kruse L; Taxter T; Beaubier N; White K; Zou L; Gerami P
J Invest Dermatol; 2020 Aug; 140(8):1599-1608. PubMed ID: 32004563
[TBL] [Abstract] [Full Text] [Related]
9. Blood-based testing for colorectal cancer screening.
Heichman KA
Mol Diagn Ther; 2014 Apr; 18(2):127-35. PubMed ID: 24307563
[TBL] [Abstract] [Full Text] [Related]
10. Bistable switch in migration stimulating factor expression: regulation by the concerted signalling of transforming growth factor-β1 and the extracellular matrix.
Schor SL; Ellis IR; Jones SJ; Woolston AM; Schor AM
Int J Cancer; 2012 May; 130(9):2024-32. PubMed ID: 21630266
[TBL] [Abstract] [Full Text] [Related]
11. Multi-factorial modulation of IGD motogenic potential in msf (migration stimulating factor).
Ellis IR; Jones SJ; Staunton D; Vakonakis I; Norman DG; Potts JR; Milner CM; Meenan NA; Raibaud S; Ohea G; Schor AM; Schor SL
Exp Cell Res; 2010 Sep; 316(15):2465-76. PubMed ID: 20403349
[TBL] [Abstract] [Full Text] [Related]
12. Co-expression by keratinocytes of migration stimulating factor (msf) and a functional inhibitor of its bioactivity (msfI).
Jones SJ; Florence MM; Ellis IR; Kankova K; Schor SL; Schor AM
Exp Cell Res; 2007 Dec; 313(20):4145-57. PubMed ID: 17949711
[TBL] [Abstract] [Full Text] [Related]
13. Multimodality expression profiling shows sept9 to be overexpressed in a wide range of human tumours.
Scott M; Hyland PL; McGregor G; Hillan KJ; Russell SE; Hall PA
Oncogene; 2005 Jul; 24(29):4688-700. PubMed ID: 15782116
[TBL] [Abstract] [Full Text] [Related]
14. Marked induction of gelatinases, especially type B, in host fibroblasts by human ovarian cancer cells in athymic mice.
Miyagi E; Yasumitsu H; Hirahara F; Nagashima Y; Minaguchi H; Miyazaki K; Umeda M
Clin Exp Metastasis; 1995 Mar; 13(2):89-96. PubMed ID: 7882618
[TBL] [Abstract] [Full Text] [Related]
15. Detection of migration stimulating activity in wound fluid.
Picardo M; Grey AM; McGurk M; Ellis I; Schor SL
Exp Mol Pathol; 1992 Aug; 57(1):8-21. PubMed ID: 1397194
[TBL] [Abstract] [Full Text] [Related]
16. Heterogeneity amongst fibroblasts in the production of migration stimulating factor (msf): implications for cancer pathogenesis.
Schor SL; Grey AM; Picardo M; Schor AM; Howell A; Ellis I; Rushton G
EXS; 1991; 59():127-46. PubMed ID: 1833226
[TBL] [Abstract] [Full Text] [Related]
17. Mechanism of action of the migration stimulating factor produced by fetal and cancer patient fibroblasts: effect on hyaluronic and synthesis.
Schor SL; Schor AM; Grey AM; Chen J; Rushton G; Grant ME; Ellis I
In Vitro Cell Dev Biol; 1989 Aug; 25(8):737-46. PubMed ID: 2768134
[TBL] [Abstract] [Full Text] [Related]
18. Purification of the migration stimulating factor produced by fetal and breast cancer patient fibroblasts.
Grey AM; Schor AM; Rushton G; Ellis I; Schor SL
Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2438-42. PubMed ID: 2488545
[TBL] [Abstract] [Full Text] [Related]
19. Fibroblasts from cancer patients display a mixture of both foetal and adult-like phenotypic characteristics.
Schor SL; Schor AM; Rushton G
J Cell Sci; 1988 Jul; 90 ( Pt 3)():401-7. PubMed ID: 3253290
[TBL] [Abstract] [Full Text] [Related]
20. Foetal and cancer patient fibroblasts produce an autocrine migration-stimulating factor not made by normal adult cells.
Schor SL; Schor AM; Grey AM; Rushton G
J Cell Sci; 1988 Jul; 90 ( Pt 3)():391-9. PubMed ID: 3253289
[TBL] [Abstract] [Full Text] [Related]
[Next]
